openPR Logo
Press release

Discover Malignant Glioma Market, 2016 - 2022

Malignant glioma’s are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. Gliomas account for around 45% of primary brain tumors where children are less likely to develop the risk of gliomas. Gliomas arise from the glial cells or non-neuronal cells hence the name and the cells are supposed to provide support and protection for neurons in the central nervous system and peripheral nervous system. Gliomas are caused due to growing or invading into or creating pressure in nearby the normal brain tissues developing tumors in the brain and spinal cord. According to the grading by WHO (World Health Organization), the grade III tumors are malignant and lead to death within 12 to 24 months. Currently more than 60% of the clinical trials in gene therapy are focused on targeting cancer.

Cancer is one of the major and global health issue faced accounting for approximately 8 million deaths globally. Heredity, geography, exposure to electromagnetic radiation and gender are some factors responsible for most of the gliomas. There is no such population or geographies where the risks for malignant glioblastoma is less hence the treatment area is much wide and has large scope for future advancements. The factors which affect this market include the limitations of chemotherapy, approvals rate for various drugs and therapies by regulatory bodies and increasing population. Lifestyle changes is one of the leading factor to acceleration of this market and indulge companies to select promising novel treatments entering the clinical arena.

The malignant glioma market can be segmented on the basis of therapy and distribution channel.

Based on the therapy the malignant glioma market can be sun-divided into following:

Chemotherapy

Drugs

Alkylating Agents
VEGF/VEGFR inhibitors
Anti angiogenic drugs

Based on the distribution channel the malignant glioma market can be sub-divided into the following:

Hospitals
Cancer Research Organizations
Long term care centers
Diagnostic Centers

Pharmaceutical companies have made significant contributions in the treatment of cancer since the past several decades along with increase in spending over cancer related R&D facilities. The market for cancer is steadily increasing due to advancements in the novel methods of treatment, product innovations and successful clinical trials conducted by pharmaceuticals. There are various activities carried out by the pharmaceuticals globally to overcome the technological challenges through mergers and acquisitions, funding and patents. Companies operating in oncology segments are pre-registering for, Pre-clinical, IND, Phase I, Phase II, Phase III.

Depending on geographic region, malignant glioma is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and prevalence cases, followed by Europe where the major pharmaceuticals have their blockbuster drugs and include the major funding associations. It is observed in a survey that 1 in 2 men and 1 in 3 women which accounts for almost 40% of the population in U.S. are at a risk of developing cancer in the coming years. The drug development costs are overriding the costs of investments in R&D and yet there are comparatively less approved drugs which pass the Phase III trials. The developing countries as India and China have a higher scope by collaborating with the large pharmaceutical industry players and develop new drugs.

Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/10076

The companies which are the major players in the malignant glioma market are Sigma-Aldrich Co. LLC., Bristol-Myers Squibb, Genentech Inc. Sun Pharmaceutical Industries Ltd., Cipla Inc., Panacea Biotec., Zydus Cadila and Merck & Co., Inc.

Request to view TOC: http://www.persistencemarketresearch.com/toc/10076

About Us:
Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We Understand that each client has a unique problem statement, and address it with our strengths.

Contact:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Discover Malignant Glioma Market, 2016 - 2022 here

News-ID: 339917 • Views: 243

More Releases from Persistence Market Research Pvt. Ltd

Global HPMC Capsules Market is expected to reach a Valuation of US$ 554.5 Mn Ove …
HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study
Vacuum Tissue Processor Technology Most Favored in the Global Tissue Processing …
Persistence Market Research has come up with a fact based analytical research study describing various aspects of the tissue processing systems market across the globe. The analysis on tissue processing systems has been systematically drafted in a new research publication titled “Tissue Processing Systems Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This comprehensive research report focuses on various developments, trends, restraints, opportunities, drivers and challenges impacting revenue growth of
Endodontics Market Is Projected To Grow At A Moderate CAGR During The Period Of …
Endodontics is associated with the dentistry segment. It involves several therapies to protect the human teeth from infections and injuries caused to the dental pulp. Generally, it is concerned with morphology, pathology as well as physiology of dental pulp and the periradicular tissues. Endodontics is important during carrying out root canal procedure in order to reduce the inflammation and to end infection. Modernization has touched the field of endodontics as
Global Home Infusion Therapy Devices Market Driven by Growing Incidence of Pain, …
According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from

All 5 Releases


More Releases for Phase

2026 Global Pharmacovigilance Market Growth Analysis by Clinical Trials Like Pre …
Global Pharmacovigilance Market 2018 report includes extensive Market analysis and industry landscape along with SWOT analysis and PESTEL analysis of the important vendors. The analysis is conducted with a blend of secondary and primary advice for inputs from participants in the industry. Pharmacovigilance industry report covers the prospects of Women’S Health P oducts in the forecast period of 2018-2026 and the scenario. Growing prevalence of adverse reactions caused by drugs, has
Reverse Phase Columns (Professional Survey Report 2017)
"Global Reverse Phase Columns Market Professional Survey Report 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
MAAT Inaugurates Versatile Phase Shifter
Company announces release of a digital recreation of Roger Schult’s analog hardware MAAT Incorporated, a manufacturer of exceptional performance professional audio solutions, today announced the release of RSPhaseShifter version 1.0, a digital implementation of the Roger Schult/German Audio Lab’s Phase Shifter 500 Series W2324 hardware. The cross–platform plug–in creates a high quality, phase shifted version of a monaural or stereo input. Available in formats for all major DAWs (Digital Audio Workstations), RSPhaseShifter
Pre-Registration, Filing Rejected/Withdrawn, Phase Iii, Phase Ii, Phase I, Precl …
"Migraine - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of
Daisho Blacksmith completes successful Beta Test Phase
Huge support from users by brisk participation at beta test • Sync release could be further optimized • Official sync release shortly available as download Munich, february 23rd 2011. The beta test for the new version of the personal information management software DAISHO was successfully completed. Daisho Blacksmith, developer of the PIM tool, would like to thank the numerous testers which have actively contributed to the enhancement of DAISHO through their dedicated testing.
Epsilon Award 2008 - Nomination phase has started
The Epsilon Award is a combination of Excellency, craftsmanship and visionary ability. These are characteristics of an outstanding programmer and a piece of true software art. And you can now send your application for nomination for this prestigious award of our software industry. Please read all details and find the relevant signup link www.euroconference.org/Epsilon_Vote.htm on the webportal of the European Software Conference 2008, taking place in Berlin on November 8